.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Fish and Richardson
Cerilliant
Cantor Fitzgerald
Deloitte
Cipla
Covington
Citi
US Department of Justice
Express Scripts

Generated: December 16, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 062664

« Back to Dashboard

NDA 062664 describes NEOMYCIN AND POLYMYXIN B SULFATE, which is a drug marketed by Watson Labs, X Gen Pharms, Akorn, Bausch And Lomb, Perrigo Co Tennessee, Alcon Pharms Ltd, Amring Pharms, Ipharm, and Sandoz Inc, and is included in twenty-one NDAs. It is available from two suppliers. Additional details are available on the NEOMYCIN AND POLYMYXIN B SULFATE profile page.

The generic ingredient in NEOMYCIN AND POLYMYXIN B SULFATE is bacitracin zinc; hydrocortisone; neomycin sulfate; polymyxin b sulfate. There are twenty-seven drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the bacitracin zinc; hydrocortisone; neomycin sulfate; polymyxin b sulfate profile page.

Summary for 062664

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 062664

Suppliers and Packaging for NDA: 062664

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NEOMYCIN AND POLYMYXIN B SULFATE neomycin sulfate; polymyxin b sulfate SOLUTION;IRRIGATION 062664 ANDA Watson Laboratories, Inc. 0591-2190 0591-2190-45 10 AMPULE in 1 CARTON (0591-2190-45) > 1 mL in 1 AMPULE (0591-2190-54)
NEOMYCIN AND POLYMYXIN B SULFATE neomycin sulfate; polymyxin b sulfate SOLUTION;IRRIGATION 062664 ANDA Watson Laboratories, Inc. 0591-2190 0591-2190-50 50 AMPULE in 1 CARTON (0591-2190-50) > 1 mL in 1 AMPULE (0591-2190-54)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;IRRIGATIONStrengthEQ 40MG BASE/ML;200,000 UNITS/ML
Approval Date:Apr 8, 1986TE:ATRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cipla
QuintilesIMS
Daiichi Sankyo
Federal Trade Commission
Colorcon
US Department of Justice
Teva
Baxter
Cerilliant
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot